Trial Profile
An open-label, multiple dose Phase I study to evaluate pharmacokinetic profile and safety of sulcardine sulfate in healthy Chinese male.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2016
Price :
$35
*
At a glance
- Drugs Sulcardine (Primary)
- Indications Arrhythmias
- Focus Adverse reactions; Pharmacokinetics
- 14 Oct 2016 New trial record
- 22 Aug 2016 Results published in the European Journal of Drug Metabolism and Pharmacokinetics